Stay updated on Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    - Revision: v3.5.2 is now displayed, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:45:03.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision badge updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:47:24.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.4.3' appears, replacing the previous 'Revision: v3.4.2'. This is a lightweight update to the page's revision label.
    Difference
    0.1%
    Check dated 2026-03-11T14:11:41.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown and the government funding/status notice has been removed, reflecting administrative updates that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:22:15.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH Clinical Center operating status was added, with links to cc.nih.gov and opm.gov. A new site revision tag v3.4.1 was introduced (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-03T23:04:26.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated QC-related labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0), plus minor capitalization changes.
    Difference
    0.2%
    Check dated 2026-01-27T21:22:08.000Z thumbnail image

Stay in the know with updates to Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page.